Lotus Set To Build New Manufacturing Facility, Pharma Park In Inner Mongolia
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Lotus Pharmaceuticals, a Beijing-based drug maker and a distributor of Western medicines, is channeling RMB 180 million ($26.3 million) into establishing a new manufacturing base and pharmaceutical park in Inner Mongolia, according to company executives